全文获取类型
收费全文 | 55篇 |
免费 | 1篇 |
国内免费 | 1篇 |
专业分类
基础医学 | 3篇 |
临床医学 | 6篇 |
内科学 | 4篇 |
皮肤病学 | 2篇 |
神经病学 | 4篇 |
特种医学 | 2篇 |
外科学 | 9篇 |
综合类 | 19篇 |
预防医学 | 1篇 |
药学 | 3篇 |
中国医学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2019年 | 2篇 |
2018年 | 2篇 |
2017年 | 2篇 |
2016年 | 1篇 |
2014年 | 2篇 |
2013年 | 6篇 |
2012年 | 2篇 |
2011年 | 10篇 |
2010年 | 5篇 |
2009年 | 7篇 |
2008年 | 3篇 |
2007年 | 6篇 |
2005年 | 3篇 |
2004年 | 1篇 |
2003年 | 1篇 |
1998年 | 1篇 |
1994年 | 1篇 |
排序方式: 共有57条查询结果,搜索用时 0 毫秒
51.
52.
Gonad-stimulating substance (GSS) of starfish is the only known invertebrate peptide hormone responsible for final gamete maturation, rendering it functionally analogous to gonadotropins in vertebrates. Recently, we purified GSS from the radial nerves of the starfish Asterina pectinifera and identified the chemical structure as a relaxin-like peptide. This study examined the hormonal action of GSS on ovaries in the growing (stage IV) and fully grown states (stage V) of the starfish. The sensitivity of oocytes to 1-methyladenine (1-MeAde) as starfish maturation-inducing hormone was enhanced as oocytes enlarged in stage V. GSS-stimulated 1-MeAde production by ovarian follicle cells was also correlated with the size of oocytes. Although 1-MeAde production was observed in whole ovaries in stage V, GSS failed to induce 1-MeAde production in young ovaries (stage IV). This suggests that follicle cells in ovaries in a growing state (stage IV) are still unresponsive to the hormonal action of GSS. According to competitive experiments using radioiodinated and radioinert GSS, however, dissociation constant (Kd) values and the number of binding sites for GSS were mostly constant in the ovaries from stages IV to V. These results strongly suggest that GSS receptors are expressed in follicle cells of ovaries in the growing state. The failure of GSS to induce 1-MeAde production in young ovaries may be due to the uncoupling of signal transduction from the receptor to 1-MeAde biosynthesis in follicle cells. 相似文献
53.
54.
55.
目的 探讨通用型脊柱内固定系统(GSS)在腰椎管狭窄症伴退变性滑脱患者手术中的应用价值。方法 对16例腰椎管狭窄症伴退变性滑脱患者行后路全椎板减压、GSS内固定加植骨融合术,其中多节段腰椎管狭窄11例,单节段腰椎管狭窄5例;L4滑脱9例,L5滑脱7例;Meyerding分类Ⅰ度滑脱14例,Ⅱ度滑脱2例。结果术后随访6—24个月,平均14个月,采用Stauffer—Coventry下腰椎术后疗效评定标准,优良率为88%,植骨融合率为100%,GSS无松动退出及断裂现象。结论在腰椎管狭窄症伴退变性滑脱后路全椎板减压术中,GSS系统可提供滑脱复位,恢复椎间隙高度及腰椎生理前凸,术后即刻稳定,植骨融合率高,是一种安全有效、操作简便的内固定系统。 相似文献
56.
57.